How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QAZ: Cancer Predisposition Risk Assessment System. View classification details, related manufacturers, 510(k) clearances, and recall records.
A qualitative in vitro molecular diagnostic system used for the detection of select variants in specified cancer-related genes. The device is intended to be used on genomic DNA isolated from human specimens collected by the user. The results of the test provide users with a genetic health risk assessment for developing certain cancers. The test may not include all variants associated with a predisposition of developing cancer and is not intended to describe a persons overall risk of developing any type of cancer nor to aid in determination of treatment or act as a substitute for recommended cancer screenings or appropriate follow-up. The device is for over-the-counter use.Explore medical genetics records →
3 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jan 18, 2019 to Aug 31, 2023.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QAZ · Cancer Predisposition Risk Assessment System | 3 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| 23andMe® Personal Genome Service® (PGS®) Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)K223597 · QAZ | 23AndMe, Inc. | 510(k) | Aug 31, 2023FDA decision date |
| 23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)K211499 · QAZ | 23AndMe, Inc. | 510(k) | Jan 6, 2022FDA decision date |
| MUTYH-Associated Polyposis (MAP)K182784 · QAZ | 23AndMe, Inc. | 510(k) | Jan 18, 2019FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.